Details

Title

Transgenic mammalian species, generated by somatic cell cloning, in biomedicine, biopharmaceutical industry and human nutrition/dietetics - recent achievements

Journal title

Polish Journal of Veterinary Sciences

Yearbook

2011

Numer

No 2

Publication authors

Divisions of PAS

Nauki Biologiczne i Rolnicze

Publisher

Polish Academy of Sciences Committee of Veterinary Sciences ; University of Warmia and Mazury in Olsztyn

Date

2011

Identifier

ISSN 1505-1773

References

A Aguirre (1998), Expression of human erythropoietin transgenes and of the endogenous WAP gene in the mammary gland of transgenic rabbits during gestation and lactation, Transgenic Res, 7, 311, doi.org/10.1023/A:1008882332133 ; A Baguisi (1999), Production of goats by somatic cell nuclear transfer, Nat Biotechnol, 17, 456, doi.org/10.1038/8632 ; M Baranyi (2007), Isolation and some effects of functional, low-phenylalanine κ-casein expressed in the milk of transgenic rabbits, J Biotechnol, 128, 383, doi.org/10.1016/j.jbiotec.2006.10.016 ; A Boaglio (2006), Features of the milk whey protein partitioning in polyethyleneglycol-sodium citrate aqueous two-phase systems with the goal of isolating human α-1-antitrypsin expressed in bovine milk, J Chromatogr B Analyt Technol Biomed Life Sci, 837, 18, doi.org/10.1016/j.jchromb.2006.03.049 ; K Bondioli (2001), Cloned pigs generated from cultured skin fibroblasts derived from a H-transferase transgenic boar, Mol Reprod Dev, 60, 189, doi.org/10.1002/mrd.1076 ; Z Bösze (2008), Producing recombinant human milk proteins in the milk of livestock species, Adv Exp Med Biol, 606, 357, doi.org/10.1007/978-0-387-74087-4_15 ; M Brink (2000), Developing efficient strategies for the generation of transgenic cattle which produce biopharmaceuticals in milk, Theriogenology, 53, 139, doi.org/10.1016/S0093-691X(99)00247-2 ; B Brophy (2003), Cloned transgenic cattle produce milk with higher levels of β-casein and κ-casein, Nat Biotechnol, 21, 157, doi.org/10.1038/nbt783 ; C Cammuso (2000), Hormonal induced lactation in transgenic goats, Anim Biotechnol, 11, 1, doi.org/10.1080/10495390009525943 ; C Chen (2002a), Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine α-lactalbumin regulation sequences, Transgenic Res, 11, 257, doi.org/10.1023/A:1015651302674 ; S Chen (2002b), Efficient production of transgenic cloned calves using preimplantation screening, Biol Reprod, 67, 1488, doi.org/10.1095/biolreprod.102.006981 ; Y Cheng (2002), Cloned goats produced from the somatic cells of an adult transgenic goat, Sheng Wu Gong Cheng Xue Bao, Chinese Journal of Biotechnology, 18, 79. ; B Choi (2000), Cation-exchange purification of mutagenized bovine β-casein expressed in transgenic mouse milk: its putative Asn68-linked glycan is heterogeneous, J Dairy Sci, 84, 44, doi.org/10.3168/jds.S0022-0302(01)74450-5 ; P Chrenek (2007), Expression of recombinant human factor VIII in milk of several generations of transgenic rabbits, Transgenic Res, 16, 353, doi.org/10.1007/s11248-007-9070-6 ; A Clark (1998), The mammary gland as a bioreactor: expression, processing, and production of recombinant proteins, J Mammary Gland Biol Neoplasia, 3, 337, doi.org/10.1023/A:1018723712996 ; E Devinoy (1994), High level production of human growth hormone in the milk of transgenic mice: the upstream region of the rabbit whey acidic protein (WAP) gene targets transgene expression to the mammary gland, Transgenic Res, 3, 79, doi.org/10.1007/BF01974085 ; Y Echelard (2005), The first biopharmaceutical from transgenic animals: Atryn®, Modern Biopharmaceuticals, 4, 11, 995, doi.org/10.1002/9783527620982.ch41 ; Y Echelard (2006), Production of recombinant therapeutic proteins in the milk of transgenic animals, BioPharm International, 19, 36. ; G Gil (2008), Analysis of the N-glycans of recombinant human Factor IX purified from transgenic pig milk, Glycobiology, 18, 526, doi.org/10.1093/glycob/cwn035 ; E Hitchin (1996), Bovine beta-casein expressed in transgenic mouse milk is phosphorylated and incorporated into micelles, Protein Expr Purif, 7, 247, doi.org/10.1006/prep.1996.0035 ; P Hyvonen (2006), Human and bovine lactoferrins in the milk of recombinant human lactoferrin-transgenic dairy cows during lactation, Biotechnol J, 1, 410, doi.org/10.1002/biot.200600016 ; G Jang (2006), An approach for producing transgenic cloned cows by nuclear transfer of cells transfected with human α1-antitrypsin gene, Theriogenology, 65, 1800, doi.org/10.1016/j.theriogenology.2005.10.014 ; T Jenkins (2006), Major advances in nutrition: impact on milk composition, J Dairy Sci, 89, 1302, doi.org/10.3168/jds.S0022-0302(06)72198-1 ; A Kind (2008), Animal pharming, two decades on, Transgenic Res, 17, 1025, doi.org/10.1007/s11248-008-9206-3 ; B Konkle (2003), Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures, Transfusion, 43, 390, doi.org/10.1046/j.1537-2995.2003.00315.x ; G Laible (2007), Compositional analysis of dairy products derived from clones and cloned transgenic cattle, Theriogenology, 67, 166, doi.org/10.1016/j.theriogenology.2006.09.028 ; C Lee (1996), An efficient expression of human growth hormone (hGH) in the milk of transgenic mice using rat β-casein/hGH fusion genes, Appl Biochem Biotechnol, 56, 211, doi.org/10.1007/BF02786953 ; J Lee (2003), Production of cloned pigs by whole-cell intracytoplasmic microinjection, Biol Reprod, 69, 995, doi.org/10.1095/biolreprod.103.015917 ; J Limonta (1995), Transgenic rabbits as bioreactors for the production of human growth hormone, J Biotechnol, 40, 49, doi.org/10.1016/0168-1656(95)00026-M ; K McCreath (2000), Production of gene-targeted sheep by nuclear transfer from cultured somatic cells, Nature, 405, 1066, doi.org/10.1038/35016604 ; D Melican (2005), Effect of serum concentration, method of trypsinization and fusion/activation utilizing transfected fetal cells to generate transgenic dairy goats by somatic cell nuclear transfer, Theriogenology, 63, 1549, doi.org/10.1016/j.theriogenology.2004.05.029 ; E Melo (2007), Animal transgenesis: state of the art and applications, J Appl Genet, 48, 47, doi.org/10.1007/BF03194657 ; T Mikus (2004), Generation and phenotypic analysis of a transgenic line of rabbits secreting active recombinant human erythropoietin in the milk, Transgenic Res, 13, 487, doi.org/10.1007/s11248-004-9596-9 ; H Nagasawa (1996), Changes of plasma levels of human growth hormone with age in relation to mammary tumour appearance in whey acidic protein/human growth hormone (mWAP/hGH) transgenic female and male mice, In Vivo, 10, 503. ; H Niemann (2007), Transgenic farm animals: an update, Reprod Fertil Dev, 19, 762, doi.org/10.1071/RD07040 ; R Paleyanda (1997), Transgenic pigs produce functional human factor VIII in milk, Nat Biotechnol, 15, 971, doi.org/10.1038/nbt1097-971 ; L Pampel (2007), The influence of major components on the direct chromatographic recovery of a protein from transgenic milk, J Chromatogr A, 1142, 137, doi.org/10.1016/j.chroma.2006.12.043 ; L Pampel (2008), A methodical approach to ultra-scale-down of process sequences: application to casein removal from the milk of transgenic animals, Biotechnol Prog, 24, 192, doi.org/10.1021/bp070218q ; M Patnaik (2008), Inherited antithrombin deficiency: a review, Haemophilia, 14, 1229, doi.org/10.1111/j.1365-2516.2008.01830.x ; S Pipe (2005), The promise and challenges of bioengineered recombinant clotting factors, J Thromb Haemost, 3, 1692, doi.org/10.1111/j.1538-7836.2005.01367.x ; J Ramsoondar (2003), Production of α1,3-galactosyltransferase-knockout cloned pigs expressing human α1,2-fucosylosyltransferase, Biol Reprod, 69, 437, doi.org/10.1095/biolreprod.102.014647 ; B Reggio (2001), Cloned transgenic off-spring resulting from somatic cell nuclear transfer in the goat: oocytes derived from both follicle-stimulating hormone-stimulated and nonstimulated abattoir-derived ovaries, Biol Reprod, 65, 1528, doi.org/10.1095/biolreprod65.5.1528 ; M Rijnkels (1998), High-level expression of bovine αS1-casein in milk of transgenic mice, Transgenic Res, 7, 5, doi.org/10.1023/A:1008892720466 ; L Sabikhi (2007), Designer milk, Adv Food Nutr Res, 53, 161, doi.org/10.1016/S1043-4526(07)53005-6 ; D Salamone (2006), High level expression of bioactive recombinant human growth hormone in the milk of a cloned transgenic cow, J Biotechnol, 124, 469, doi.org/10.1016/j.jbiotec.2006.01.005 ; M Samiec (2003), Effect of activation treatments on the in vitro developmental potential of porcine nuclear transfer embryos, Czech J Anim Sci, 48, 499. ; M Samiec (2005a), The role of mitochondrial genome (mtDNA) in somatic and embryo cloning of mammals, J Anim Feed Sci, 14, 213, doi.org/10.22358/jafs/67008/2005 ; M Samiec (2005b), The effect of mitochondrial genome on architectural remodeling and epigenetic reprogramming of donor cell nuclei in mammalian nuclear transfer-derived embryos, J Anim Feed Sci, 14, 393. ; M Samiec (2005), Molecular conditions of the cell nucleus remodelling/reprogramming process and nuclear-transferred embryo development in the intraooplasmic karyoplast injection technique, Czech J Anim Sci, 50, 185. ; A Schnieke (1997), Human factor IX transgenic sheep produced by transfer of nuclei from transfected fetal fibroblasts, Science, 278, 2130, doi.org/10.1126/science.278.5346.2130 ; M Skrzyszowska (2006), Generation of transgenic rabbits by the novel technique of chimeric somatic cell cloning, Biol Reprod, 74, 1114, doi.org/10.1095/biolreprod.104.039370 ; M Skrzyszowska (2008), Development of porcine transgenic nuclear-transferred embryos derived from fibroblast cells transfected by the novel technique of nucleofection or standard lipofection, Theriogenology, 70, 248, doi.org/10.1016/j.theriogenology.2008.04.007 ; A Thomson (2003), Gene targeting in livestock, Reprod Suppl, 61, 495. ; K Van Cott (2004), Haemophilic factors produced by transgenic live-stock: abundance that can enable alternative therapies worldwide, Haemophilia 10 Suppl, 4, 70, doi.org/10.1111/j.1365-2516.2004.00983.x ; Wang B, Zhou J (<b>2003</b>) Specific genetic modifications of domestic animals by gene targeting and animal cloning. Reprod Biol Endocrinol 1, published online, doi: 10.1186/1477-7827-1-103: 103-110. ; A Wrathall (2000), Risk of transmission of spongiform encephalopathies by reproductive technologies in domesticated ruminants, Livest Prod Sci, 62, 287, doi.org/10.1016/S0301-6226(99)00163-3 ; J Yan (2006), Transgenic mice can express mutant human coagulation factor IX with higher level of clotting activity, Biochem Genet, 44, 349. ; Z Yu (2006), Expression and bioactivity of recombinant human lysozyme in the milk of transgenic mice, J Dairy Sci, 89, 2911, doi.org/10.3168/jds.S0022-0302(06)72563-2 ; Q Zhou (2005), Effect of genetic background on glycosylation heterogeneity in human antithrombin produced in the mammary gland of transgenic goats, J Biotechnol, 117, 57, doi.org/10.1016/j.jbiotec.2005.01.001 ; K Zuelke (1998), Transgenic modification of cows milk for value-added processing, Reprod Fertil Dev, 10, 671, doi.org/10.1071/RD98068

DOI

10.2478/v10181-011-0050-7

×